Karus Therapeutics
Latest round
- Series B
Last raised
- Jun 2012
Total raised
- $11M
Investors
- 5
About Karus Therapeutics
Karus Therapeutics engages in the development of best-in-class medicines to treat inflammatory disease and cancer.
Who invested in Karus Therapeutics
5 investors across 1 round
See all investors in Karus Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jun 12, 2012
Amount
$11M
Investors
Questions about Karus Therapeutics
Who invested in Karus Therapeutics?
Karus Therapeutics has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Karus Therapeutics raised?
Karus Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Karus Therapeutics last raise money?
Karus Therapeutics's most recent round on record is a Series B, in Jun 2012.
What does Karus Therapeutics do?
Karus Therapeutics engages in the development of best-in-class medicines to treat inflammatory disease and cancer.
Where is Karus Therapeutics headquartered?
Karus Therapeutics is headquartered in UK.
Which VCs invest in companies like Karus Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at Karus Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Karus Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.